Global Medical Foods For Inborn Errors Of Metabolism Market
Marktgröße in Milliarden USD
CAGR : %
Prognosezeitraum |
2024 –2031 |
Marktgröße (Basisjahr) | USD 2,477.81 Million |
Marktgröße (Prognosejahr) | USD 7,998.77 Million |
CAGR |
|
Wichtige Marktteilnehmer |
|
>Globaler Markt für medizinische Lebensmittel für angeborene Stoffwechselstörungen, nach Produkten (Aminosäure, proteinarme Lebensmittel, Glytactin mit GMP-Aminosäure-modifizierter Säuglingsnahrung mit Eisen, kalziumarmer/Vitamin-D-freier Säuglingsnahrung mit Eisen und anderen), Krankheiten (Phenylketonurie (PKU), Ryrosinämie Typ I und II, Ahornsirupkrankheit (MSUD), Homocystinurie, Glutarazidurie Typ I, Harnstoffzyklusstörungen, Methylmalonazidurie, Isovalerianazidurie, organische Azidurien, Nierenerkrankungen, Propionsäure-Akademie, Störungen des Leucinstoffwechsels und anderen), Altersgruppe (Säuglinge, Entwöhnung, Jugendliche und Erwachsene), Formen (Pulver, Flüssigkeit, Tabletten, Gele und andere), Verpackung (Dose, Glas, Päckchen, Flasche und andere), Vertriebskanal (Einzelhandelsapotheke, Krankenhausapotheke, Online-Apotheke, Drogerie und andere) – Branchentrends und Prognosen für 2031.
Medizinische Lebensmittel für angeborene Stoffwechselstörungen – Marktanalyse und -größe
Ein Anstieg der Fälle angeborener Stoffwechselstörungen (IEM) und die Bevorzugung von Nahrungsergänzungsmitteln gegenüber Enzymersatztherapien (ERT) dürften das Marktwachstum ankurbeln. Der Mangel an Erstattungsmöglichkeiten für diese medizinischen Nahrungsmittel und auch ihre hohen Kosten könnten das Marktwachstum bremsen.
Data Bridge Market Research analysiert, dass der globale Markt für medizinische Lebensmittel für angeborene Stoffwechselstörungen im Prognosezeitraum von 2023 bis 2031 voraussichtlich mit einer durchschnittlichen jährlichen Wachstumsrate von 14,1 % wachsen und von 2.477,81 Millionen US-Dollar im Jahr 2023 auf 7.998,77 Millionen US-Dollar im Jahr 2031 ansteigen wird.
Der globale Marktbericht zu medizinischen Nahrungsmitteln für angeborene Stoffwechselstörungen enthält Einzelheiten zu Marktanteilen, neuen Entwicklungen und dem Einfluss inländischer und lokaler Marktteilnehmer, analysiert Chancen in Bezug auf neu entstehende Umsatzquellen, Änderungen der Marktvorschriften, Produktzulassungen, strategische Entscheidungen, Produkteinführungen, geografische Expansionen und technologische Innovationen auf dem Markt. Um die Analyse und das Marktszenario zu verstehen, kontaktieren Sie uns für ein Analystenbriefing. Unser Team hilft Ihnen bei der Entwicklung einer umsatzwirksamen Lösung, um Ihr gewünschtes Ziel zu erreichen.
Berichtsmetrik |
Details |
Prognosezeitraum |
2023 bis 2031 |
Basisjahr |
2022 |
Historische Jahre |
2021 (anpassbar auf 2015–2020) |
Quantitative Einheiten |
Umsatz in Mio. USD |
Abgedeckte Segmente |
Produkte (Aminosäure, eiweißarme Nahrung, Glytactin mit GMP-Aminosäure-modifizierter Säuglingsanfangsnahrung mit Eisen, kalziumarme/Vitamin-D-freie Säuglingsanfangsnahrung mit Eisen und andere), Krankheiten ( Phenylketonurie (PKU), Ryrosinämie Typ I und II, Ahornsirupkrankheit (MSUD), Homocystinurie, Glutarazidurie Typ I, Harnstoffzyklusstörungen, Methylmalonazidurie , Isovalerianazidurie, organische Azidurie, Nierenerkrankung, Propionsäureämie, Störungen des Leucinstoffwechsels und andere), Altersgruppe (Säuglinge, Entwöhnung, Jugendliche und Erwachsene), Darreichungsformen (Pulver, Flüssigkeit, Tabletten, Gele und andere), Verpackung (Dose, Glas, Päckchen, Flasche und andere), Vertriebskanal (Einzelhandelsapotheke, Krankenhausapotheke, Online-Apotheke, Drogerie und andere) |
Abgedeckte Länder |
USA, Kanada, Mexiko, Deutschland, Frankreich, Großbritannien, Italien, Spanien, Russland, Türkei, Belgien, Niederlande, Schweiz, Polen, Finnland, Dänemark, Schweden, Norwegen, übriges Europa, Japan, China, Indien, Südkorea, Australien, Singapur, Thailand, Malaysia, Indonesien, Neuseeland, Vietnam, Philippinen, Taiwan, übriger Asien-Pazifik-Raum, Brasilien, Argentinien, übriges Südamerika, Südafrika, Saudi-Arabien, Bahrain, Vereinigte Arabische Emirate, Kuwait, Katar, Ägypten, Oman und übriger Naher Osten und Afrika |
Abgedeckte Marktteilnehmer |
Nutricia, Abbott, Baxter, Nestlé Health Science, Meiji Holdings Co., Ltd., Hexagon Nutrition Ltd, Kate Farms, Primus Pharmaceuticals, inc., Promin, Ajinomoto Cambrooke, Inc., Galen Limited, Piam Farmaceutici SPA, Orpharma Pty Ltd., PKU-Mdmil.com, B. Braun SE, Pristine Organics Pvt Ltd., Mead Johnson & Company, LLC., EBM Medical, Biovencer Healthcare Pvt Ltd und Solace Nutrition, unter anderem |
Marktdefinition
Angeborene Stoffwechselstörungen (IEM) sind eine Gruppe von Störungen, bei denen der Körper nicht in der Lage ist, Nahrung in Energie umzuwandeln. Aufgrund von Genmutationen werden bestimmte Enzyme, die für den Abbau bestimmter Substanzen verantwortlich sind, weniger oder gar nicht produziert. Dieser Abbau führt zur Ansammlung bestimmter giftiger Substanzen und hat schwere Komplikationen zur Folge. Zur Behandlung dieser Störungen erhalten die betroffenen Patienten unter ärztlicher Aufsicht spezielle Diäten, die auch als medizinische Nahrung bezeichnet werden. Phenylketonurie (PKU) beispielsweise ist eine Krankheit, bei der es zu einer Ansammlung einer Aminosäure namens Phenylalanin kommt. Dies kann zu geistiger Behinderung, Krampfanfällen und vielen anderen psychischen Störungen führen. Zur Behandlung erhalten die Patienten IEM-Diäten wie Phenylketonuria (PKU)-1, hergestellt von Pristine Organics Pvt Ltd.
Globale Marktdynamik für medizinische Lebensmittel gegen angeborene Stoffwechselstörungen
Treiber
- Steigende Fälle angeborener Stoffwechselstörungen (IEM)
Fortschrittliche Diagnosemethoden spielen eine wesentliche Rolle bei der zunehmenden Akzeptanz von IEM. In der Vergangenheit wurden diese Erkrankungen aufgrund begrenzter Informationen und Diagnoseinstrumente häufig falsch diagnostiziert oder übersehen. Fortschritte in der Medizintechnik und bei genetischen Tests haben jedoch unsere Fähigkeit verändert, IEM genau zu diagnostizieren. Fortschrittliche Technologien wie Sequenzierung der nächsten Generation und biochemische Analysen ermöglichen es medizinischen Fachkräften, bestimmte genetische Mutationen oder Anomalien in Stoffwechselwegen zu identifizieren, die mit diesen Erkrankungen in Zusammenhang stehen. Diese verbesserte Diagnosegenauigkeit hat zur erhöhten Inzidenz von IEM beigetragen. So haben Fortschritte in der Sequenzierungstechnologie der nächsten Generation es beispielsweise ermöglicht, seltene IEM-Varianten zu identifizieren, die zuvor schwer zu lokalisieren waren. Dies ermöglichte eine genauere und umfassendere Diagnose dieser Erkrankungen.
- Zunehmende Präferenz für Nahrungsergänzungsmittel gegenüber Enzymersatztherapie (ERT)
Die zunehmende Bevorzugung von Nahrungsergänzungsmitteln gegenüber der Enzymersatztherapie (ERT) bei der Behandlung von IEM kann mehrere Gründe haben. Erstens bieten Nahrungsergänzungsmittel einen nichtinvasiven und bequemen Behandlungsansatz. Im Gegensatz zur ERT, bei der häufig eine Injektion oder Infusion erforderlich ist, können Nahrungsergänzungsmittel oral eingenommen werden, was sie für Patienten attraktiver macht, die eine weniger invasive Option wünschen. Darüber hinaus bieten Nahrungsergänzungsmittel eine umfassende Ernährungsunterstützung, da sie verschiedene Nährstoffe, Cofaktoren und Substrate enthalten, die für einen optimalen Stoffwechsel erforderlich sind. Dieses breitere Spektrum der Unterstützung behebt mehrere Stoffwechseldefizite, die mit bestimmten IEM verbunden sind, was zu einer wirksameren Behandlung der Erkrankung führen kann.
Die zunehmende Beliebtheit von Nahrungsergänzungsmitteln hat zu einer steigenden Nachfrage nach speziellen medizinischen Nahrungsmitteln geführt, die den besonderen Ernährungsbedürfnissen von IEM-Patienten gerecht werden. Dies vergrößerte den Markt und veranlasste die Hersteller, eine breitere Produktpalette zu entwickeln, um dieser Nachfrage gerecht zu werden. Darüber hinaus förderte die Vorliebe für Nahrungsergänzungsmittel die Forschung und Entwicklung zur Verbesserung der Zusammensetzung und Wirksamkeit medizinischer Nahrungsmittel, was zur Verwendung neuer und besserer Alternativen führte. Daher wird erwartet, dass die zunehmende Präferenz für Nahrungsergänzungsmittel gegenüber ERT bei der Behandlung von IEM das Marktwachstum vorantreiben wird.
Gelegenheiten
- Regierungsinitiativen und -programme zur Sensibilisierung für angeborene Stoffwechselstörungen
Regierungen auf der ganzen Welt haben erkannt, wie wichtig es ist, das Bewusstsein für IEM zu schärfen, und haben verschiedene Initiativen und Programme umgesetzt, um diesem Bedarf gerecht zu werden. Diese Initiativen zielen darauf ab, medizinisches Fachpersonal, von IEM betroffene Personen und Familien sowie die breite Öffentlichkeit zu informieren. Hier sind einige Regierungsinitiativen und -programme zur Sensibilisierung für IEM. Regierungsinitiativen und -programme zur Sensibilisierung für IEM bieten Marktchancen und fördern die Nachfrage nach Diagnoseinstrumenten, Therapieverfahren und Spezialprodukten. Diese Initiativen fördern auch Forschung und Entwicklung, erleichtern die Markterweiterung durch internationale Zusammenarbeit und bieten Unternehmen in diesem Bereich Finanzierung und Unterstützung. Daher wird erwartet, dass Regierungsinitiativen und -programme zur Sensibilisierung für IEM eine Chance für Marktwachstum bieten.
Einschränkung/Herausforderung
- Hohe Kosten für medizinische Lebensmittel
Die hohen Kosten für medizinische Lebensmittel sind auf viele Faktoren zurückzuführen, die die Kosten ihrer Produktion, Entwicklung und Verteilung beeinflussen. Erstens erfordern spezielle medizinische Lebensmittel umfangreiche Forschung und Entwicklung. Hersteller investieren in wissenschaftliche Forschung und klinische Studien, um die optimale Kombination aus Nährstoffen, bioaktiven Verbindungen und Therapeutika zur Behandlung bestimmter Gesundheitszustände zu finden. Diese Studie erfordert das Fachwissen von Ernährungswissenschaftlern und Gesundheitsexperten, was die Gesamtkosten erhöht. Die hohen Kosten für medizinische Lebensmittel sind eine Marktbeschränkung, da sie die Erschwinglichkeit und Marktreichweite einschränken. Hohe Preise machen diese speziellen Ernährungsprodukte für viele Menschen unerschwinglich. Daher wird erwartet, dass die hohen Kosten für medizinische Lebensmittel das Marktwachstum bremsen.
Jüngste Entwicklungen
- Im Oktober 2023 gaben Nestlé Health Science und Amwell eine Zusammenarbeit bekannt, um Gesundheitsorganisationen dabei zu helfen, die allgemeine Gesundheit der Patienten durch innovative digitale Lösungen mit Schwerpunkt auf Ernährung zu verbessern. Gemeinsam entwickeln die Unternehmen ein Portfolio neuartiger Lösungen zur Verbesserung klinischer und finanzieller Ergebnisse. Dies wird das Markenimage beider Unternehmen verbessern
- Im März 2021 brachte Meiji Co., Ltd. unter Danones Marke Aptamil Säuglingsmilch in Tablettenform in Großbritannien auf den Markt. Die Tabletten mit vordosierten Tabs sollen für Eltern praktisch sein. Die Produktion begann in Wexford, Irland, wobei Meijis Technologie mit Danones Rezepturen kombiniert wurde. Danone plant, das Produkt ab 2022 in andere europäische Länder zu bringen. Meiji strebt an, den Auslandsumsatz bis zum Geschäftsjahr 2026 auf 10 % zu steigern
Globaler Markt für medizinische Lebensmittel gegen angeborene Stoffwechselstörungen
Der globale Markt für medizinische Lebensmittel für angeborene Stoffwechselstörungen ist in sechs wichtige Segmente unterteilt, basierend auf Produkten, Krankheiten, Altersgruppe, Formen, Verpackung und Vertriebskanal. Das Wachstum dieser Segmente hilft Ihnen bei der Analyse wichtiger Wachstumssegmente in den Branchen und bietet den Benutzern einen wertvollen Marktüberblick und Markteinblicke, um strategische Entscheidungen zur Identifizierung der wichtigsten Marktanwendungen zu treffen.
Produkte
- Aminosäure
- Proteinarme Lebensmittel
- Glytactin mit GMP Aminosäuremodifizierte Säuglingsnahrung mit Eisen
- Calciumarme/Vitamin-D-freie Säuglingsnahrung mit Eisen
- Sonstiges
Auf der Grundlage der Produkte ist der globale Markt für medizinische Lebensmittel für angeborene Stoffwechselstörungen in Aminosäuren, Glytactin mit GMP-Aminosäure-modifizierter Säuglingsanfangsnahrung mit Eisen, kalziumarme/Vitamin-D-freie Säuglingsanfangsnahrung mit Eisen, eiweißarme Nahrung und andere unterteilt.
Krankheiten
- Phenylketonurie (PKU)
- Tyrosinämie Typ I und II
- Ahornsirupkrankheit (MSUD)
- Homocystinurie
- Glutarazidurie Typ I
- Harnstoffzyklusstörungen
- Methylmalonazidämie
- Isovalerianazidämie
- Organische Acidurien
- Nierenerkrankung
- Propionazidämie
- Störungen des Leucinstoffwechsels
- Sonstiges
Auf der Grundlage von Krankheiten ist der globale Markt für medizinische Nahrungsmittel gegen angeborene Stoffwechselstörungen in Phenylketonurie (PKU), Tyrosinämie Typ I und II, Ahornsirupkrankheit (MSUD), Homocystinurie, Glutarazidurie Typ I, Harnstoffzyklusstörungen, Methylmalonazidurie, Isovalerianazidurie, organische Azidurie, Nierenerkrankungen, Propionsäureämie, Störungen des Leucinstoffwechsels und andere unterteilt.
Altersgruppe
- Kleinkinder
- Entwöhnung
- Jugendliche
- Erwachsene
Auf Grundlage der Altersgruppen ist der globale Markt für medizinische Nahrungsmittel für angeborene Stoffwechselstörungen in Säuglinge, Entwöhnung, Jugendliche und Erwachsene segmentiert.
Formulare
- Pulver
- Flüssig
- Tablets
- Gele
- Sonstiges
Auf der Grundlage der Form ist der globale Markt für medizinische Nahrungsmittel für angeborene Stoffwechselstörungen in Pulver, Flüssigkeiten, Tabletten, Gele und andere Produkte unterteilt.
Verpackung
- Kann
- Pakete
- Flasche
- Krug
- Sonstiges
Auf Grundlage der Verpackung ist der globale Markt für medizinische Lebensmittel für angeborene Stoffwechselstörungen in Dosen, Gläser, Päckchen, Flaschen und Sonstiges unterteilt.
Vertriebskanal
- Krankenhausapotheke
- Einzelhandelsapotheke
- Drogerien
- Online-Apotheke
- Sonstiges
Auf der Grundlage der Vertriebskanäle ist der globale Markt für medizinische Lebensmittel für angeborene Stoffwechselstörungen in Einzelhandelsapotheken, Krankenhausapotheken, Online-Apotheken, Drogerien und andere unterteilt.
Globale Marktanalyse für medizinische Lebensmittel für angeborene Stoffwechselstörungen – Regionale Erkenntnisse
Der globale Markt für medizinische Lebensmittel für angeborene Stoffwechselstörungen ist basierend auf Produkten, Krankheiten, Altersgruppe, Formen, Verpackung und Vertriebskanälen in sechs wichtige Segmente unterteilt.
Die Länder auf dem globalen Markt für medizinische Lebensmittel für angeborene Stoffwechselstörungen sind die USA, Kanada, Mexiko, Deutschland, Frankreich, Großbritannien, Italien, Spanien, Russland, Türkei, Belgien, Niederlande, Schweiz, Polen, Finnland, Dänemark, Schweden, Norwegen, übriges Europa, Japan, China, Indien, Südkorea, Australien, Singapur, Thailand, Malaysia, Indonesien, Neuseeland, Vietnam, Philippinen, Taiwan, übriger asiatisch-pazifischer Raum, Brasilien, Argentinien, übriges Südamerika, Südafrika, Saudi-Arabien, Bahrain, Vereinigte Arabische Emirate, Kuwait, Katar, Ägypten, Oman sowie der Rest des Nahen Ostens und Afrikas.
Nordamerika wird voraussichtlich den globalen Markt für medizinische Nahrungsmittel für angeborene Stoffwechselstörungen dominieren, da es über eine hochmoderne Gesundheitsinfrastruktur, intensive Forschungsanstrengungen, strenge behördliche Aufsicht, ein erhöhtes öffentliches Bewusstsein für diese Erkrankungen, einen weit verbreiteten Zugang zu umfassendem Versicherungsschutz und proaktive Regierungspolitik verfügt. Die USA werden voraussichtlich die Region Nordamerika dominieren, da die Hersteller innovative Lösungen für die Behandlung seltener genetischer Erkrankungen anbieten und daher in dieser Region hohe Umsätze erzielt werden. China wird voraussichtlich die Region Asien-Pazifik dominieren, da es einen Wettbewerbsvorteil in Bezug auf Produktionseffizienz und Kosteneffizienz hat. Deutschland wird voraussichtlich die Region Europa dominieren, da die Hersteller viele verbesserte und fortschrittliche Produkte auf diesem Markt einführen.
Der Länderabschnitt des Berichts enthält auch einzelne marktbeeinflussende Faktoren und Änderungen der Marktregulierung, die sich auf die aktuellen und zukünftigen Trends des Marktes auswirken. Datenpunktanalysen der nachgelagerten und vorgelagerten Wertschöpfungskette, technische Trends, Porters Fünf-Kräfte-Analyse und Fallstudien sind einige der Hinweise, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Bereitstellung von Prognoseanalysen der Länderdaten werden auch die Präsenz und Verfügbarkeit globaler Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken, die Auswirkungen inländischer Zölle und Handelsrouten berücksichtigt.
Wettbewerbsumfeld und globale medizinische Lebensmittel für angeborene Stoffwechselstörungen Marktanteilsanalyse
Die Wettbewerbslandschaft des globalen Marktes für medizinische Lebensmittel für angeborene Stoffwechselstörungen liefert Details zu den Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Produktionsstandorte und -anlagen, Stärken und Schwächen des Unternehmens, Produkteinführung, Produkttestpipelines, Produktzulassungen, Patente, Produktbreite und -umfang, Anwendungsdominanz, Technologie-Lebenslinienkurve. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus der Unternehmen in Bezug auf den globalen Markt für medizinische Lebensmittel für angeborene Stoffwechselstörungen.
Zu den prominenten Teilnehmern auf dem globalen Markt für medizinische Nahrungsmittel gegen angeborene Stoffwechselstörungen zählen unter anderem Nutricia, Abbott, Baxter, Nestlé Health Science, Meiji Holdings Co., Ltd., Hexagon Nutrition Ltd, Kate Farms, Primus Pharmaceuticals, inc., Promin, Ajinomoto Cambrooke, Inc., Galen Limited, Piam Farmaceutici SPA, Orpharma Pty Ltd., PKU-Mdmil.com, B. Braun SE, Pristine Organics Pvt Ltd., Mead Johnson & Company, LLC., EBM Medical, Biovencer Healthcare Pvt Ltd und Solace Nutrition.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 DBMR MARKET POSITION GRID
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 EPIDEMIOLOGY
4.1.1 PREVALENCE OF INBORN ERRORS OF METABOLISM
4.1.2 NEW-BORN SCREENING PROGRAMS
4.1.3 GENETIC HETEROGENEITY
4.1.4 IMPACT ON HEALTH
4.1.5 CLINICAL IMPAC
4.1.6 TREATMENT AND MANAGEMENT
4.2 PESTLE ANALYSIS
4.2.1 POLITICAL FACTORS
4.2.2 ECONOMIC FACTORS
4.2.3 SOCIAL FACTORS
4.2.4 TECHNOLOGICAL FACTORS
4.2.5 ENVIRONMENTAL FACTORS
4.2.6 LEGAL FACTORS
4.3 PORTER’S FIVE FORCES
4.3.1 THREAT OF NEW ENTRANTS
4.3.2 THREAT OF SUBSTITUTES
4.3.3 BARGAINING POWER OF BUYERS
4.3.4 BARGAINING POWER OF SUPPLIERS
4.3.5 COMPETITIVE RIVALRY
4.4 INDUSTRY INSIGHTS
4.4.1 DEMOGRAPHIC TRENDS
4.4.2 KEY PRICING STRATEGIES
4.4.3 KEY PATIENT ENROLLMENT STRATEGIES
4.5 PATENT ANALYSIS
4.6 PIPELINE ANALYSIS
4.6.1 RESEARCH AND DEVELOPMENT
4.6.2 CLINICAL TRIALS
4.6.3 REGULATORY APPROVAL
4.6.4 MANUFACTURING AND PRODUCTION
4.6.5 COMMERCIALIZATION AND MARKET ACCESS
4.6.6 DISTRIBUTION AND SUPPLY CHAIN MANAGEMENT
4.6.7 POST-MARKET SURVEILLANCE AND MONITORING
4.7 REGULATION COVERAGE
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING INCIDENCES OF INBORN ERRORS OF METABOLISM (IEM)
5.1.2 RISING PREFERENCE FOR DIETARY SUPPLEMENTS OVER ENZYME REPLACEMENT THERAPY (ERT)
5.1.3 INCREASE IN THE NUMBER OF NEW-BORN SCREENING PROCEDURES
5.1.4 INCREASING SPENDING ON MEDICAL FOOD PRODUCTS
5.2 RESTRAINTS
5.2.1 HIGH COST OF MEDICAL FOODS
5.2.2 STRINGENT REGULATIONS FOR MEDICAL FOODS
5.3 OPPORTUNITIES
5.3.1 GOVERNMENT INITIATIVES AND PROGRAMS FOR CREATING AWARENESS ABOUT INBORN ERRORS OF METABOLISM
5.3.2 INCREASING COLLABORATIONS AND PARTNERSHIPS IN THE MARKET
5.3.3 EXPANSION OF MEDICAL FOODS IN EMERGING MARKETS
5.4 CHALLENGES
5.4.1 POOR ACCESSIBILITY OF MEDICAL FOODS
5.4.2 ALTERNATIVE TREATMENT APPROACHES FOR INBORN ERRORS OF METABOLISM
6 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS
6.1 OVERVIEW
6.2 AMINO ACID
6.2.1 AMINO ACID, BY PRODUCTS
6.2.1.1 amino acid mixtures, BY products
6.2.1.2 phenylade, BY products
6.2.1.1 single amino acids, BY products
6.3 LOW PROTEIN FOOD
6.3.1 LOW PROTEIN FOOD, BY PRODUCTS
6.4 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON
6.4.1 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON, BY FLAVORS
6.4.2 GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON, BY USAGES
6.5 LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON
6.5.1 LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON, BY PRODUCTS
6.6 OTHERS
7 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES
7.1 OVERVIEW
7.2 PHENYLKETONURIA (PKU)
7.2.1 PHENYLKETONURIA (PKU), BY DISEASES
7.3 TYROSINEMIA TYPES I AND II
7.4 MAPLE SYRUP URINE DISEASE (MSUD)
7.4.1 MAPLE SYRUP URINE DISEASE (MSUD), BY DISEASES
7.5 HOMOCYSTINURIA
7.5.1 GLUTARIC ACIDEMIA TYPE I
7.6 UREA CYCLE DISORDERS
7.6.1 UREA CYCLE DISORDERS, BY DISEASES
7.7 METHYLMALONIC ACIDEMIA
7.7.1 ISOVALERIC ACIDEMIA
7.8 ORGANIC ACIDURIAS
7.9 RENAL DISEASE
7.1 PROPIONIC ACIDEMIA
7.11 DISORDERS OF LEUCINE METABOLISM
7.12 OTHERS
8 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 INFANTS
8.3 WEANING
8.4 ADOLESCENT
8.5 ADULTS
9 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS
9.1 OVERVIEW
9.2 POWDER
9.3 LIQUID
9.4 TABLETS
9.5 GELS
9.6 OTHERS
10 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING
10.1 OVERVIEW
10.2 CAN
10.3 PACKETS
10.4 BOTTLE
10.5 JAR
10.6 OTHERS
11 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 HOSPITAL PHARMACY
11.3 RETAIL PHARMACY
11.4 DRUG STORES
11.5 ONLINE PHARMACY
11.6 OTHERS
12 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION
12.1 OVERVIEW
12.2 NORTH AMERICA
12.2.1 U S
12.2.2 CANADA
12.2.3 MEXICO
12.3 EUROPE
12.3.1 GERMANY
12.3.2 FRANCE
12.3.3 U K
12.3.4 ITALY
12.3.5 SPAIN
12.3.6 SWITZERLAND
12.3.7 NETHERLAND
12.3.8 BELGIUM
12.3.9 DENMARK
12.3.10 RUSSIA
12.3.11 SWEDEN
12.3.12 TURKEY
12.3.13 POLAND
12.3.14 FINLAND
12.3.15 REST OF EUROPE
12.4 ASIA-PACIFIC
12.4.1 CHINA
12.4.2 JAPAN
12.4.3 INDIA
12.4.4 AUSTRALIA
12.4.5 SOUTH KOREA
12.4.6 THAILAND
12.4.7 SINGAPORE
12.4.8 INDONESIA
12.4.9 MALASIA
12.4.10 NEW ZEALAND
12.4.11 VIETNAM
12.4.12 PHILIPPINES
12.4.13 TAIWAN
12.4.14 REST OF ASIA-PACIFIC
12.5 SOUTH AMERICA
12.5.1 BRAZIL
12.5.2 ARGENTINA
12.5.3 REST OF SOUTH AMERICA
12.6 MIDDLE EAST AND AFRICA
12.6.1 SOUTH AFRICA
12.6.2 SAUDI ARABIA
12.6.3 BAHRAIN
12.6.4 UNITED ARAB EMIRATES
12.6.5 KUWAIT
12.6.6 QATAR
12.6.7 EGYPT
12.6.8 OMAN
12.6.9 REST OF MIDDLE EAST AND AFRICA
13 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 ABBOTT
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 NESTLÉ HEALTH SCIENCE (A SUBSIDIARY OF NESTLÉ)
15.2.1 COMPANY SNAPSHOT
15.2.2 COMPANY SHARE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENTS
15.3 MEIJI HOLDINGS CO., LTD.
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 BAXTER
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 PRISTINE ORGANICS PVT LTD.
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 AJINOMOTO CAMBROOKE, INC. (A SUBSIDIARY OF AJINOMOTO CO., INC.)
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 B.BRAUN SE
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 BIOVENCER HEALTHCARE PVT LTD
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 EBM MEDICAL
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 GALEN LIMITED
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 HEXAGON NUTRITION LTD.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 KATE FARMS
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 MEAD JOHNSON & COMPANY, LLC. (A SUBSIDIARY OF RECKITT BENCKISER GROUP PLC.)
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 NUTRICIA (A SUBSIDIARY OF DANONE)
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 ORPHARMA PTY LTD.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 PIAM FARMACEUTICI S.P.A
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 PKU-MDMIL
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 PRIMUS PHARMACEUTICALS, INC.
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 PROMIN
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 SOLACE NUTRITION
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 COSTS OF MEDICAL FOODS USED IN INBORN ERRORS OF METABOLISM (IEMS)
TABLE 2 PATENT ANALYSIS
TABLE 3 REGULATORY COVERAGE
TABLE 4 COSTS OF MEDICAL FOODS
TABLE 5 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 6 GLOBAL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 7 GLOBAL AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 8 GLOBAL AMINO ACIDS MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 9 GLOBAL PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 10 GLOBAL SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 11 GLOBAL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 12 GLOBAL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 13 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 14 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 15 GLOBAL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 16 GLOBAL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 17 GLOBAL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 18 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 19 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 20 GLOBAL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 21 GLOBAL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 22 GLOBAL TYROSINEMIA TYPES I AND II IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 23 GLOBAL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 24 GLOBAL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 25 GLOBAL HOMOCYSTINURIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 26 GLOBAL GLUTARIC ACIDEMIA TYPE I IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 27 GLOBAL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 28 GLOBAL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 29 GLOBAL METHYLMALONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 30 GLOBAL ISOVALERIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 31 GLOBAL ORGANIC ACIDURIAS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 32 GLOBAL RENAL DISEASE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 33 GLOBAL PROPIONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 34 GLOBAL DISORDERS OF LEUCINE METABOLISM IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 35 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 36 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 37 GLOBAL INFANTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 38 GLOBAL WEANING IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 39 GLOBAL ADOLESCENT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 40 GLOBAL ADULTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 41 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 42 GLOBAL POWDER IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 43 GLOBAL LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 44 GLOBAL TABLETS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 45 GLOBAL GELS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 46 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 47 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 48 GLOBAL CAN IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 49 GLOBAL LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 50 GLOBAL BOTTLE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 51 GLOBAL JAR IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 52 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 53 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 54 GLOBAL HOSPITAL PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 55 GLOBAL RETAIL PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 56 GLOBAL DRUG STORES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 57 GLOBAL ONLINE PHARMACY IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 58 GLOBAL OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 59 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2031 (USD THOUSAND)
TABLE 60 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)
TABLE 61 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 62 NORTH AMERICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 63 NORTH AMERICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 64 NORTH AMERICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 65 NORTH AMERICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 66 NORTH AMERICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 67 NORTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 68 NORTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 69 NORTH AMERICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 70 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 71 NORTH AMERICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 72 NORTH AMERICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 73 NORTH AMERICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 74 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 75 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 76 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 77 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 78 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 79 U.S. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 80 U.S. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 81 U.S. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 82 U.S. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 83 U.S. LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 84 U.S. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 85 U.S. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 86 U.S. LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 87 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 88 U.S. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 89 U.S. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 90 U.S. UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 91 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 92 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 93 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 94 U.S. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 95 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 96 CANADA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 97 CANADA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 98 CANADA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 99 CANADA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 100 CANADA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 101 CANADA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 102 CANADA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 103 CANADA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 104 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 105 CANADA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 106 CANADA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 107 CANADA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 108 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 109 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 110 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 111 CANADA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 112 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 113 MEXICO AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 114 MEXICO AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 115 MEXICO PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 116 MEXICO SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 117 MEXICO LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 118 MEXICO GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 119 MEXICO GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 120 MEXICO LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 121 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 122 MEXICO PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 123 MEXICO MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 124 MEXICO UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 125 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 126 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 127 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 128 MEXICO MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 129 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)
TABLE 130 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 131 EUROPE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 132 EUROPE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 133 EUROPE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 134 EUROPE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 135 EUROPE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 136 EUROPE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 137 EUROPE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 138 EUROPE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 139 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 140 EUROPE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 141 EUROPE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 142 EUROPE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 143 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 144 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 145 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 146 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 147 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 148 GERMANY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 149 GERMANY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 150 GERMANY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 151 GERMANY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 152 GERMANY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 153 GERMANY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 154 GERMANY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 155 GERMANY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 156 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 157 GERMANY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 158 GERMANY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 159 GERMANY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 160 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 161 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 162 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 163 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 164 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 165 FRANCE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 166 FRANCE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 167 FRANCE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 168 FRANCE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 169 FRANCE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 170 FRANCE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 171 FRANCE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 172 FRANCE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 173 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 174 FRANCE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 175 FRANCE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 176 FRANCE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 177 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 178 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 179 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 180 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 181 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 182 U.K. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 183 U.K. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 184 U.K. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 185 U.K. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 186 U.K. LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 187 U.K. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 188 U.K. GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 189 U.K. LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 190 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 191 U.K. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 192 U.K. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 193 U.K. UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 194 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 195 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 196 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 197 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 198 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 199 ITALY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 200 ITALY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 201 ITALY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 202 ITALY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 203 ITALY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 204 ITALY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 205 ITALY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 206 ITALY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 207 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 208 ITALY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 209 ITALY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 210 ITALY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 211 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 212 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 213 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 214 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 215 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 216 SPAIN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 217 SPAIN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 218 SPAIN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 219 SPAIN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 220 SPAIN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 221 SPAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 222 SPAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 223 SPAIN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 224 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 225 SPAIN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 226 SPAIN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 227 SPAIN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 228 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 229 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 230 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 231 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 232 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 233 SWITZERLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 234 SWITZERLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 235 SWITZERLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 236 SWITZERLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 237 SWITZERLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 238 SWITZERLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 239 SWITZERLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 240 SWITZERLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 241 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 242 SWITZERLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 243 SWITZERLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 244 SWITZERLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 245 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 246 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 247 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 248 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 249 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 250 NETHERLANDS AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 251 NETHERLANDS AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 252 NETHERLANDS PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 253 NETHERLANDS SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 254 NETHERLANDS LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 255 NETHERLANDS GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 256 NETHERLANDS GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 257 NETHERLANDS LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 258 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 259 NETHERLANDS PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 260 NETHERLANDS MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 261 NETHERLANDS UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 262 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 263 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 264 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 265 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 266 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 267 BELGIUM AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 268 BELGIUM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 269 BELGIUM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 270 BELGIUM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 271 BELGIUM LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 272 BELGIUM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 273 BELGIUM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 274 BELGIUM LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 275 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 276 BELGIUM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 277 BELGIUM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 278 BELGIUM UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 279 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 280 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 281 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 282 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 283 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 284 DENMARK AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 285 DENMARK AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 286 DENMARK PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 287 DENMARK SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 288 DENMARK LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 289 DENMARK GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 290 DENMARK GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 291 DENMARK LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 292 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 293 DENMARK PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 294 DENMARK MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 295 DENMARK UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 296 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 297 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 298 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 299 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 300 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 301 RUSSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 302 RUSSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 303 RUSSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 304 RUSSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 305 RUSSIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 306 RUSSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 307 RUSSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 308 RUSSIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 309 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 310 RUSSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 311 RUSSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 312 RUSSIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 313 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 314 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 315 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 316 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 317 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 318 SWEDEN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 319 SWEDEN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 320 SWEDEN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 321 SWEDEN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 322 SWEDEN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 323 SWEDEN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 324 SWEDEN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 325 SWEDEN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 326 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 327 SWEDEN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 328 SWEDEN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 329 SWEDEN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 330 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 331 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 332 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 333 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 334 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 335 TURKEY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 336 TURKEY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 337 TURKEY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 338 TURKEY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 339 TURKEY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 340 TURKEY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 341 TURKEY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 342 TURKEY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 343 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 344 TURKEY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 345 TURKEY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 346 TURKEY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 347 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 348 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 349 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 350 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 351 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 352 POLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 353 POLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 354 POLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 355 POLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 356 POLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 357 POLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 358 POLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 359 POLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 360 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 361 POLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 362 POLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 363 POLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 364 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 365 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 366 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 367 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 368 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 369 FINLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 370 FINLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 371 FINLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 372 FINLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 373 FINLAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 374 FINLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 375 FINLAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 376 FINLAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 377 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 378 FINLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 379 FINLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 380 FINLAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 381 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 382 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 383 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 384 FINLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 385 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 386 NORWAY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 387 NORWAY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 388 NORWAY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 389 NORWAY LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 390 NORWAY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 391 NORWAY GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 392 NORWAY LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 393 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 394 NORWAY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 395 NORWAY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 396 NORWAY UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 397 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 398 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 399 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 400 NORWAY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 401 REST OF EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 402 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)
TABLE 403 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 404 ASIA-PACIFIC AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 405 ASIA-PACIFIC AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 406 ASIA-PACIFIC PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 407 ASIA-PACIFIC SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 408 ASIA-PACIFIC LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 409 ASIA-PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 410 ASIA-PACIFIC GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 411 ASIA-PACIFIC LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 412 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 413 ASIA-PACIFIC PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 414 ASIA-PACIFIC MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 415 ASIA-PACIFIC UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 416 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 417 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 418 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 419 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 420 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 421 CHINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 422 CHINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 423 CHINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 424 CHINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 425 CHINA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 426 CHINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 427 CHINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 428 CHINA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 429 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 430 CHINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 431 CHINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 432 CHINA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 433 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 434 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 435 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 436 CHINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 437 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 438 JAPAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 439 JAPAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 440 JAPAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 441 JAPAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 442 JAPAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 443 JAPAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 444 JAPAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 445 JAPAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 446 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 447 JAPAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 448 JAPAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 449 JAPAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 450 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 451 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 452 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 453 JAPAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 454 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 455 INDIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 456 INDIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 457 INDIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 458 INDIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 459 INDIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 460 INDIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 461 INDIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 462 INDIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 463 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 464 INDIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 465 INDIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 466 INDIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 467 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 468 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 469 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 470 INDIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 471 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 472 AUSTRALIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 473 AUSTRALIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 474 AUSTRALIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 475 AUSTRALIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 476 AUSTRALIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 477 AUSTRALIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 478 AUSTRALIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 479 AUSTRALIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 480 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 481 AUSTRALIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 482 AUSTRALIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 483 AUSTRALIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 484 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 485 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 486 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 487 AUSTRALIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 488 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 489 SOUTH KOREA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 490 SOUTH KOREA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 491 SOUTH KOREA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 492 SOUTH KOREA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 493 SOUTH KOREA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 494 SOUTH KOREA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 495 SOUTH KOREA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 496 SOUTH KOREA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 497 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 498 SOUTH KOREA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 499 SOUTH KOREA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 500 SOUTH KOREA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 501 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 502 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 503 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 504 SOUTH KOREA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 505 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 506 THAILAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 507 THAILAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 508 THAILAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 509 THAILAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 510 THAILAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 511 THAILAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 512 THAILAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 513 THAILAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 514 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 515 THAILAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 516 THAILAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 517 THAILAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 518 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 519 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 520 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 521 THAILAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 522 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 523 SINGAPORE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 524 SINGAPORE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 525 SINGAPORE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 526 SINGAPORE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 527 SINGAPORE LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 528 SINGAPORE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 529 SINGAPORE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 530 SINGAPORE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 531 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 532 SINGAPORE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 533 SINGAPORE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 534 SINGAPORE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 535 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 536 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 537 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 538 SINGAPORE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 539 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 540 INDONESIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 541 INDONESIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 542 INDONESIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 543 INDONESIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 544 INDONESIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 545 INDONESIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 546 INDONESIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 547 INDONESIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 548 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 549 INDONESIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 550 INDONESIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 551 INDONESIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 552 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 553 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 554 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 555 INDONESIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 556 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 557 MALAYSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 558 MALAYSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 559 MALAYSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 560 MALAYSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 561 MALAYSIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 562 MALAYSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 563 MALAYSIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 564 MALAYSIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 565 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 566 MALAYSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 567 MALAYSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 568 MALAYSIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 569 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 570 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 571 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 572 MALAYSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 573 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 574 NEW ZEALAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 575 NEW ZEALAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 576 NEW ZEALAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 577 NEW ZEALAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 578 NEW ZEALAND LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 579 NEW ZEALAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 580 NEW ZEALAND GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 581 NEW ZEALAND LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 582 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 583 NEW ZEALAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 584 NEW ZEALAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 585 NEW ZEALAND UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 586 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 587 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 588 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 589 NEW ZEALAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 590 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 591 VIETNAM AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 592 VIETNAM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 593 VIETNAM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 594 VIETNAM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 595 VIETNAM LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 596 VIETNAM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 597 VIETNAM GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 598 VIETNAM LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 599 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 600 VIETNAM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 601 VIETNAM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 602 VIETNAM UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 603 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 604 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 605 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 606 VIETNAM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 607 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 608 PHILIPPINES AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 609 PHILIPPINES AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 610 PHILIPPINES PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 611 PHILIPPINES SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 612 PHILIPPINES LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 613 PHILIPPINES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 614 PHILIPPINES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 615 PHILIPPINES LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 616 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 617 PHILIPPINES PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 618 PHILIPPINES MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 619 PHILIPPINES UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 620 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 621 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 622 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 623 PHILIPPINES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 624 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 625 TAIWAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 626 TAIWAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 627 TAIWAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 628 TAIWAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 629 TAIWAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 630 TAIWAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 631 TAIWAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 632 TAIWAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 633 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 634 TAIWAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 635 TAIWAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 636 TAIWAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 637 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 638 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 639 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 640 TAIWAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 641 REST OF ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 642 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031 (USD THOUSAND)
TABLE 643 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 644 SOUTH AMERICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 645 SOUTH AMERICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 646 SOUTH AMERICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 647 SOUTH AMERICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 648 SOUTH AMERICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 649 SOUTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 650 SOUTH AMERICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 651 SOUTH AMERICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 652 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 653 SOUTH AMERICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 654 SOUTH AMERICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 655 SOUTH AMERICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 656 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 657 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 658 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 659 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 660 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 661 BRAZIL AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 662 BRAZIL AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 663 BRAZIL PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 664 BRAZIL SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 665 BRAZIL LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 666 BRAZIL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 667 BRAZIL GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 668 BRAZIL LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 669 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 670 BRAZIL PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 671 BRAZIL MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 672 BRAZIL UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 673 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 674 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 675 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 676 BRAZIL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 677 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 678 ARGENTINA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 679 ARGENTINA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 680 ARGENTINA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 681 ARGENTINA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 682 ARGENTINA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 683 ARGENTINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031 (USD THOUSAND)
TABLE 684 ARGENTINA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031 (USD THOUSAND)
TABLE 685 ARGENTINA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 686 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 687 ARGENTINA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 688 ARGENTINA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 689 ARGENTINA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031 (USD THOUSAND)
TABLE 690 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031 (USD THOUSAND)
TABLE 691 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031 (USD THOUSAND)
TABLE 692 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031 (USD THOUSAND)
TABLE 693 ARGENTINA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031 (USD THOUSAND)
TABLE 694 REST OF SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 695 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2031(USD THOUSAND)
TABLE 696 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 697 MIDDLE EAST AND AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031 (USD THOUSAND)
TABLE 698 MIDDLE EAST AND AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 699 MIDDLE EAST AND AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 700 MIDDLE EAST AND AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 701 MIDDLE EAST AND AFRICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 702 MIDDLE EAST AND AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 703 MIDDLE EAST AND AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 704 MIDDLE EAST AND AFRICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 705 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 706 MIDDLE EAST AND AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 707 MIDDLE EAST AND AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 708 MIDDLE EAST AND AFRICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 709 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 710 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 711 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 712 MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 713 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 714 SOUTH AFRICA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 715 SOUTH AFRICA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 716 SOUTH AFRICA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 717 SOUTH AFRICA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 718 SOUTH AFRICA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 719 SOUTH AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 720 SOUTH AFRICA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 721 SOUTH AFRICA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 722 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 723 SOUTH AFRICA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 724 SOUTH AFRICA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 725 SOUTH AFRICA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 726 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 727 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 728 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 729 SOUTH AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 730 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 731 SAUDI ARABIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 732 SAUDI ARABIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 733 SAUDI ARABIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 734 SAUDI ARABIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 735 SAUDI ARABIA LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 736 SAUDI ARABIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 737 SAUDI ARABIA GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 738 SAUDI ARABIA LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 739 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 740 SAUDI ARABIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 741 SAUDI ARABIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 742 SAUDI ARABIA UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 743 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 744 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 745 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 746 SAUDI ARABIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 747 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 748 BAHRAIN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 749 BAHRAIN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 750 BAHRAIN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 751 BAHRAIN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 752 BAHRAIN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 753 BAHRAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 754 BAHRAIN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 755 BAHRAIN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 756 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 757 BAHRAIN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 758 BAHRAIN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 759 BAHRAIN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 760 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 761 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 762 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 763 BAHRAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 764 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 765 UNITED ARAB EMIRATES AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 766 UNITED ARAB EMIRATES AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 767 UNITED ARAB EMIRATES PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 768 UNITED ARAB EMIRATES SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 769 UNITED ARAB EMIRATES LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 770 UNITED ARAB EMIRATES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 771 UNITED ARAB EMIRATES GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 772 UNITED ARAB EMIRATES LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 773 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 774 UNITED ARAB EMIRATES PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 775 UNITED ARAB EMIRATES MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 776 UNITED ARAB EMIRATES UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 777 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 778 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 779 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 780 UNITED ARAB EMIRATES MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 781 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 782 KUWAIT AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 783 KUWAIT AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 784 KUWAIT PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 785 KUWAIT SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 786 KUWAIT LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 787 KUWAIT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 788 KUWAIT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 789 KUWAIT LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 790 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 791 KUWAIT PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 792 KUWAIT MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 793 KUWAIT UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 794 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 795 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 796 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 797 KUWAIT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 798 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 799 QATAR AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 800 QATAR AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 801 QATAR PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 802 QATAR SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 803 QATAR LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 804 QATAR GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 805 QATAR GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 806 QATAR LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 807 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 808 QATAR PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 809 QATAR MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 810 QATAR UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 811 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 812 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 813 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 814 QATAR MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 815 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 816 EGYPT AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 817 EGYPT AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 818 EGYPT PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 819 EGYPT SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 820 EGYPT LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 821 EGYPT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 822 EGYPT GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 823 EGYPT LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 824 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 825 EGYPT PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 826 EGYPT MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 827 EGYPT UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 828 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 829 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 830 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 831 EGYPT MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 832 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 833 OMAN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 834 OMAN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 835 OMAN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 836 OMAN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 837 OMAN LOW PROTEIN FOOD IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 838 OMAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FLAVORS, 2018-2031(USD THOUSAND)
TABLE 839 OMAN GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY USAGES, 2018-2031(USD THOUSAND)
TABLE 840 OMAN LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
TABLE 841 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 842 OMAN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 843 OMAN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 844 OMAN UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2031(USD THOUSAND)
TABLE 845 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2031(USD THOUSAND)
TABLE 846 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORMS, 2018-2031(USD THOUSAND)
TABLE 847 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2031(USD THOUSAND)
TABLE 848 OMAN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2031(USD THOUSAND)
TABLE 849 REST OF MIDDLE EAST AND AFRICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2031(USD THOUSAND)
Abbildungsverzeichnis
FIGURE 1 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SEGMENTATION
FIGURE 2 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SEGMENTATION
FIGURE 9 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE THE FASTEST-GROWING REGION WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2031
FIGURE 10 A RISE IN THE INCIDENCE OF INBORN ERRORS OF METABOLISM AND AN INCREASE IN THE NUMBER OF THE NEWBORN SCREENING PROCEDURES ARE EXPECTED TO DRIVE THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2031
FIGURE 11 THE AMINO ACID SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET IN 2023 AND 2031
FIGURE 12 ASIA-PACIFIC IS THE MAXIMUM GROWING REGION FOR THE GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2031
FIGURE 13 EPIDEMIOLOGY
FIGURE 14 PORTER’S FIVE FORCES
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET
FIGURE 16 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PRODUCTS, 2022
FIGURE 17 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISEASES, 2022
FIGURE 18 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY AGE GROUP, 2022
FIGURE 19 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY FORMS, 2022
FIGURE 20 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY PACKAGING, 2022
FIGURE 21 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 22 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2022)
FIGURE 23 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: SNAPSHOT (2022)
FIGURE 24 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET : SNAPSHOT (2022)
FIGURE 25 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET:SNAPSHOT (2022)
FIGURE 26 SOUTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET:SNAPSHOT (2022)
FIGURE 27 MIDDLE EAST AND AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET:SNAPSHOT (2022)
FIGURE 28 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)
FIGURE 29 NORTH AMERICA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)
FIGURE 30 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)
FIGURE 31 ASIA-PACIFIC MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET: COMPANY SHARE 2023 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.